Clinical Trial Update: CSL Behring Sclero XIII [Phase 2]

View source ↗

Summary

An update on a Phase 2 trial of Sclero XIII for systemic sclerosis, sponsored by University College London, with CSL Behring involved; current status is unknown…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Drugs mentioned

• Sclero XIII

Snippet

Sponsor: University College, London | Conditions: Systemic Sclerosis | Phase 2 | Status: UNKNOWN